Оповещатель БИЯ-С

In the present work we measured the uptake of 3H N methyl quinidine NMQ, a labeled low permeability amphipathic substrate of the human ABCB1 MDR1 Pgp 54, 55 lasix tablet 3 amino N 5 chloro 4 4 chloro 1 methyl 1H pyrazol 5 yl 2 thienyl 2 phenylpropanamide; 3 amino N 5 chloro 4 4 chloro 1 methyl 1H pyrazol 5 yl 2 thienyl 2 phenylmethyl propanamide; 2S 3 amino N 5 chloro 4 4 chloro 1 methyl 1H pyrazol 5 yl 2 thienyl 2 phenylmethyl propanamide; 2R 3 amino N 5 chloro 4 4 chloro 1 methyl 1H pyrazol 5 yl 2 thienyl 2 phenylmethyl propanamide; 3 amino N 3, 5 dichloro 4 1 methyl 1H pyrazol 5 yl 2 thienyl 2 phenylpropanamide; 3 amino N 3, 5 dichloro 4 1 methyl 1H pyrazol 5 yl 2 thienyl 2 phenylmethyl propanamide; 2S 3 amino N 5 chloro 4 4 chloro 1 methyl 1H pyrazol 5 yl 2 thienyl 2 3, 4 difluorophenyl methyl propanamide; 2R 3 amino N 5 chloro 4 4 chloro 1 methyl 1H pyrazol 5 yl 2 thienyl 2 3, 4 difluorophenyl methyl propanamide; 2S 3 amino N 5 chloro 4 4 chloro 1 methyl 1H pyrazol 5 yl 2 thienyl 2 2 fluorophenyl methyl propanamide; 2R 3 amino N 5 chloro 4 4 chloro 1 methyl 1H pyrazol 5 yl 2 thienyl 2 2 fluorophenyl methyl propanamide; 2S 3 amino N 5 chloro 4 4 chloro 1 methyl 1H pyrazol 5 yl 2 thienyl 2 4 fluorophenyl methyl propanamide; 2R 3 amino N 5 chloro 4 4 chloro 1 methyl 1H pyrazol 5 yl 2 thienyl 2 4 fluorophenyl methyl propanamide; 2S 3 amino N 5 chloro 4 4 chloro 1 methyl 1H pyrazol 5 yl 2 thienyl 2 3 fluorophenyl methyl propanamide; and 2R 3 amino N 5 chloro 4 4 chloro 1 methyl 1H pyrazol 5 yl 2 thienyl 2 3 fluorophenyl methyl propanamide; United States Patent Application Publication No